Authors
Tayfun Senkulak, Thorsten Böker, Thomas Aretz
Published in
Die Ophthalmologie. Oct 26, 2026. Epub Oct 26, 2026.
Abstract
Bilateral diffuse uveal melanocytic proliferation (BDUMP) is a rare paraneoplastic syndrome characterized by pigmentary and angiographic abnormalities, choroidal thickening, and serous retinal detachments. In patients receiving immune checkpoint inhibitor therapy, differentiation from immune checkpoint inhibitor-associated serous chorioretinopathy may be particularly challenging.
We report the case of a 55-year-old patient with lymphogenically metastatic chromophobe renal cell carcinoma receiving nivolumab and ipilimumab who developed progressive bilateral visual loss and multiple choroidal pigmentary changes. Multimodal imaging revealed bilateral serous detachments of the neurosensory retina, subretinal hyperreflective material, and exudative macular changes. The constellation of findings initially raised suspicion of BDUMP. However, a definitive diagnosis could not be established because essential investigations, including EDI-OCT, B-scan ultrasonography, and adequately documented assessment were unavailable. At the same time, immune checkpoint inhibitor-associated serous chorioretinopathy remained an important differential diagnosis. During continued immune checkpoint inhibitor therapy, the exudative changes progressed markedly over three months, accompanied by a decline in visual acuity to 0.1 in both eyes.
This case illustrates the diagnostic dilemma between BDUMP and immune checkpoint inhibitor-associated serous chorioretinopathy. The available findings do not permit a definitive distinction, and the clinical course is not diagnostically discriminatory. Comprehensive multimodal imaging and close interdisciplinary collaboration are essential for diagnostic assessment.
PMID:
42931923
Bibliographic data and abstract were imported from PubMed on 27 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 15
- Comments 0